CannaPharmaRX Statistics
Total Valuation
CannaPharmaRX has a market cap or net worth of 1.97 million. The enterprise value is 20.40 million.
Market Cap | 1.97M |
Enterprise Value | 20.40M |
Important Dates
The last earnings date was Friday, August 15, 2025.
Earnings Date | Aug 15, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
CannaPharmaRX has 656.27 million shares outstanding. The number of shares has increased by 45.39% in one year.
Current Share Class | 656.27M |
Shares Outstanding | 656.27M |
Shares Change (YoY) | +45.39% |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 3.81% |
Owned by Institutions (%) | n/a |
Float | 607.90M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 1.45 |
PB Ratio | -0.09 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -3.61 |
EV / Sales | 14.99 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.04
Current Ratio | 0.04 |
Quick Ratio | 0.01 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -1.56 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -18.77% |
Return on Invested Capital (ROIC) | n/a |
Return on Capital Employed (ROCE) | 19.91% |
Revenue Per Employee | 52,355 |
Profits Per Employee | -217,557 |
Employee Count | 26 |
Asset Turnover | 0.12 |
Inventory Turnover | 3.99 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -69.52% in the last 52 weeks. The beta is -1,571.44, so CannaPharmaRX's price volatility has been lower than the market average.
Beta (5Y) | -1,571.44 |
52-Week Price Change | -69.52% |
50-Day Moving Average | 0.00 |
200-Day Moving Average | 0.01 |
Relative Strength Index (RSI) | 52.45 |
Average Volume (20 Days) | 107,968 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | 0.00 |
Income Statement
In the last 12 months, CannaPharmaRX had revenue of 1.36 million and -5.66 million in losses. Loss per share was -0.01.
Revenue | 1.36M |
Gross Profit | -3.19M |
Operating Income | -3.48M |
Pretax Income | -5.66M |
Net Income | -5.66M |
EBITDA | -3.44M |
EBIT | -3.48M |
Loss Per Share | -0.01 |
Balance Sheet
The company has 16,975 in cash and 17.82 million in debt, giving a net cash position of -17.80 million or -0.03 per share.
Cash & Cash Equivalents | 16,975 |
Total Debt | 17.82M |
Net Cash | -17.80M |
Net Cash Per Share | -0.03 |
Equity (Book Value) | -22.57M |
Book Value Per Share | -0.04 |
Working Capital | -27.76M |
Cash Flow
Operating Cash Flow | -1.77M |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | -234.54% |
Operating Margin | -255.73% |
Pretax Margin | -415.54% |
Profit Margin | n/a |
EBITDA Margin | -252.75% |
EBIT Margin | -255.73% |
FCF Margin | n/a |
Dividends & Yields
CannaPharmaRX does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -45.39% |
Shareholder Yield | n/a |
Earnings Yield | -287.30% |
FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
CannaPharmaRX has an Altman Z-Score of -16.3 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -16.3 |
Piotroski F-Score | 3 |